AOD 9604 is a peptide used to promote fat loss, improve metabolism, support joint health, and assist with recovery
GH therapy for growth hormone deficiency in adults has been shown to reduce fat mass by 2.1 kg and increase lean mass by an equal amount, supporting the use of GHRPs like Ipamorelin for body composition improvement (Newman et al., JCEM)
Longer-term use (6+ months) may create more durable improvements where enhanced dermal architecture supports ongoing collagen synthesis at rates intermediate between treatment peaks and pre-treatment baseline, potentially maintaining 40-60% of peak improvements indefinitely without continuous peptide application
is the Monash University Node leader of the ARC Industrial Transformation Training Centre for Cryo-electron Microscopy of Membrane Proteins (CCeMMP) (grant ID: IC200100052), which received support from Novo Nordisk for the current project
Researchers have linked these effects to tissue repair gene activation patterns, although its unclear whether the copper, peptide, or their dynamic interaction causes the impact [2]
GHK-Cu functions as a potent modulator of gene expression, influencing over 4,000 human genes related to tissue remodeling, inflammation control, and wound healing